← All organizations

Guangdong Xiangxue Precision Medical Technology Co., Ltd.

Academic/Hospital

Also known as: Guangdong Xiangxue Precision Medical Technology Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jul 8, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

genetically engineered ny-eso-1-specific t lymphocytes

Phase 1 (1 own, 0 via acquisition)

taest16001

Indications

Studied for

Sarcoma

Recent trials (2)

NCT05549921CollaboratorPhase 2Jul 8, 2022
NCT04318964CollaboratorPhase 1Mar 20, 2020

Details

Last known activity: Jul 8, 2022